COMP <GO>
CPRI vs PG // REVENUE GROWTH (YOY)
Capri Holdings Limited (NYSE) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: CPRI 2
— PG 11
▲ REVENUE GROWTH (YOY) LEADER: PG
LAST: $18.68 (+16.31%) • MKT CAP: $1.83B
revenue-growth
-4.10%
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
revenue-growth
0.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CPRI VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CPRI | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 62.30% | 51.20% | +11.10 | CPRI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.40% | 25.40% | -15.00 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 24.8x | 16.2x | +8.60 | PG | /valuation <GO> |
| Free Cash Flow Yield | 0.77% | 3.77% | -3.00 | PG | /fcf-yield <GO> |
| Operating Margin | 0.70% | 24.30% | -23.60 | PG | /operating-margins <GO> |
| Net Profit Margin | 2.30% | 19.00% | -16.70 | PG | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | -4.10% | 0.30% | -4.40 | PG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.32 | 5.59 | -2.27 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.7 | 60.3 | -7.60 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.87 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.5x | 21.7x | -0.20 | CPRI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.83B | $372.21B | -$370.39B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CPRI REV | PG REV | CPRI GROSS % | PG GROSS % | CPRI FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.47B | $84.28B | 62.3% | 51.2% | $14.0M | $14.04B |
| FY 2024 | $3.62B | $84.04B | 62.2% | 51.4% | $207.0M | $16.52B |
| FY 2023 | $4.14B | $82.01B | — | — | $309.0M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CPRI // BETA —
PG // BETA 0.87